medigraphic.com
SPANISH

Revista de Investigación Clínica

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2006, Number 3

<< Back Next >>

Rev Invest Clin 2006; 58 (3)

Molecular characterization of alpha-thalassemia in the Mexican population

Reyes-Núñez V, Garcés-Eisele J, Jorge S, Kimura E, Ferreira-Costa F, Sonati MF, Ruiz-Reyes G
Full text How to cite this article

Language: English
References: 18
Page: 23
PDF size: 52.96 Kb.


Key words:

Thalassemia, Anemia, Mexico.

ABSTRACT

Background. α-Thalassemia (α-Thal) has been poorly characterized at the molecular level in Mexico. Methods. 106 consecutive individuals identified in Laboratorios Clínicos de Puebla, with either hypochromia (MCH ‹ 24 pg) and/or microcytosis (MCV ‹ 75 fl in women or ‹ 80 fl in man), without iron deficiency, with or without anemia were investigated in this study, along a 16 month-period. α and β-Thal were looked for, the former were characterized at the molecular level.Results. Out of the 106 consecutive cases with hypochromia and/or microcytosis and normal levels of protoporphyrin zinc complex, 48 cases (45.3%) had thalassemia (37 cases of β-Thal and 11 cases of α-Thal), whereas in 58 cases (54.7%) a definite diagnosis could not be established. Of the α-Thal cases, 8 were heterozygous and two were homozygous for the −α3.7 deletion, whereas one case was heterozygous for the α2Hph allele.Conclusions. Only few of the α-Thal alleles tested were found, thus the α-thalassemic mutations, present in the studied population, seem to be rather heterogeneous.


REFERENCES

  1. Ruiz-Reyes G. Hemoglobinopatías y talasemias. In: Ruiz-Argüelles GJ (Ed.). Fundamentos de Hematología, 3a Ed. México: Editorial Médica Panamericana; 2003, pp. 132-54.

  2. Lukens JN. The thalassemias and related disorders: Quantitative disorders of hemoglobin synthesis. In: Lee GR, Foerster J, Lukens J, Paraskevas F, Greer JP, Rodgers GM (editors). Wintrobe’s Clinical Hematology. 10th Ed. Baltimore, USA: Williams & Wilkins; 1999, pp. 1405-48.

  3. Ruiz-Reyes G. Abnormal hemoglobins and thalassemia in Mexico. Rev Invest Clin 1998; 50: 163-70.

  4. Ruiz-Argüelles GJ, López-Martínez B, Ruiz-Reyes G. Heterozygous beta-thalassemia: Not infrequent in Mexico. Arch Med Res 2001; 32: 293-5.

  5. Perea FJ, Magaña MT, Cobián JG, Sánchez-López JY, Chávez ML, Zamudio G, Esparza MA, López-Guido B, Ibarra B. Molecular spectrum of β−thalassemias in the Mexican population. Blood Cells Mol Dis 2004; 33: 150-2.

  6. Reyes-Cruz G, Ruiz-Reyes G, Hernández-Acasiete M. Identificación de un foco de talasemia beta en Tamiahua, Veracruz. Rev Invest Clin 1990; 42: 189-92.

  7. Lisker R, Ruiz-Reyes G, López G, Peral-López AM, Zárate G. Características hereditarias de la población mexicana. Estudio de una comunidad de origen italiano. Rev Invest Clin 1966; 18: 11-21.

  8. Ibarra B, Perea FJ, Villalobos-Arámbula AR. Alelos talasémicos en mestizos mexicanos. Rev Invest Clin 1995; 47: 127-31.

  9. Casas-Castañeda M, Hernández-Lugo I, Torres O, Barajas H, Cibrian S, Zamudio G, Villalobos-Arámbula AR, Hermosillo-Bañuelos RM, Perea FJ, Ibarra B. Alpha-thalassemia in a selected population of Mexico. Rev Invest Clin 1998; 50: 395-8.

  10. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: A laboratory manual. 2nd Ed. Cold Spring Harbor Laboratory Press. 1989.

  11. Baysal E, Huisman THJ. Detection of common deletional alpha-thalassemia-2 determinants by PCR. Am J Hematol 1994; 46: 208-13.

  12. Bergstrome-Jones AK, Poon A. Evaluation of a single-tube multiplex polymerase chain reaction screen for detection of common alpha-thalassemia genotypes in a clinical laboratory. Am J Clin Pathol 2002; 118: 18-24.

  13. Tan ASC, Quah C, Low PS, Chong SS. A Rapid and Reliable 7- Deletion Multiplex Polymerase Chain Reaction Assay for α-Thalassemia. Blood 2001; 98: 250-1.

  14. Kattamis AC, Camaschella C, Sivera P, Surrey S, Fortina P. Human alpha-thalassemia syndromes: detection of molecular defects. Am J Hematol 1996; 53: 81-91.

  15. Dode C, Rochette J, Krishnamoorthy R. Locus assignment of human alpha globin mutations by selective amplification and direct sequencing. Br J Haematol 1990; 76: 275-81.

  16. Ruiz-Argüelles GJ, Ramírez-Cisneros F, Rivadeneyra L, Ruiz-Delgado MA, Molina-Alavez A. La frecuencia de las anemias megaloblásticas en la práctica privada en Puebla, México: Experiencia de 17 años. Medicina Univ 1999; 1: 165-7.

  17. Beutler E. The common anemias. J Am Med Assoc 1988; 259: 2433-7.

  18. Ruiz-Reyes G. Los síndromes talasémicos no son infrecuentes en la población mexicana y se subdiagnostican y confunden con deficiencias de hierro. Medicina Univ 1999; 1: 67-73.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Invest Clin. 2006;58